Medical Weight Loss & GLP-1 Programs
Semaglutide — Once-Weekly GLP-1 Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a class of medication originally developed for type 2 diabetes that has reshaped the medical weight-loss landscape. By mimicking the natural GLP-1 hormone, semaglutide modulates appetite signaling, slows gastric emptying, and improves blood-sugar regulation. At Vivere Drip Therapy in Carmel and Salinas, CA, semaglutide is offered as part of a structured program with labs, dose titration, and ongoing care-team support.
How Semaglutide Works
Semaglutide binds to GLP-1 receptors in the brain, pancreas, and gastrointestinal tract. In the hypothalamus it dampens hunger and food-noise signaling. In the gut it slows gastric emptying, so meals feel satisfying with smaller portions and satiety lasts longer. In the pancreas it enhances glucose-dependent insulin secretion, which helps stabilize blood sugar without driving hypoglycemia in non-diabetic patients. The cumulative effect is a meaningful, sustained reduction in caloric intake without the willpower-against-hunger experience most diets create.
Dosing & Titration
Semaglutide is administered as a once-weekly subcutaneous injection. Doses are titrated gradually — typically starting at a low initiation dose and stepping up every four weeks based on tolerance and response. Slow titration is the single most important strategy for minimizing nausea and gastrointestinal side effects. Your provider will personalize the schedule based on how you respond at each dose level.
What to Expect
Many patients notice reduced appetite and earlier satiety within the first week or two. Measurable weight loss typically emerges over the first one to three months and continues progressively at higher doses. Average results in clinical trials have shown sustained weight loss in the 12–15% range of body weight over a year of consistent use, paired with lifestyle changes. Vivere's program includes baseline labs, periodic check-ins, and adjustments to keep you on track and comfortable throughout treatment.
Frequently Asked Questions
Is Semaglutide the same as Ozempic or Wegovy?
Semaglutide is the active ingredient in both Ozempic (approved for diabetes) and Wegovy (approved for weight loss). Compounded semaglutide — what most concierge programs use — is the same molecule formulated through a licensed compounding pharmacy. Your provider will discuss the formulation used in your program.
How long do people stay on Semaglutide?
Semaglutide is generally considered a long-term medication for weight maintenance, much like medications for blood pressure or cholesterol. Some patients taper off after reaching their goal weight; others continue at a maintenance dose. The right approach depends on your physiology, lifestyle, and provider guidance.
What are the most common side effects?
Mild to moderate nausea is the most common side effect, especially during dose titration. Constipation, fatigue, and occasional headaches can also occur. Most side effects diminish within days as your body adapts to each dose. Severe or persistent symptoms warrant a check-in with the care team.
These therapies are offered as part of individualized medical weight-loss programs supervised by a licensed clinician and are not a substitute for evaluation of underlying medical conditions. Suitability, dosing, and program structure are determined by your provider based on your full health history. Information provided here is educational, not medical advice.
Related Topics
Book a Consultation
Every weight-loss program at Vivere is individualized. Book a consultation at our Carmel or Salinas clinic — or via telehealth from anywhere in the U.S. — to learn whether GLP-1 therapy is the right next step for you.